RING finger 1 mutations in Parkin produce altered localization of the protein

被引:136
作者
Cookson, MR
Lockhart, PJ
O'Farrell, C
Schlossmacher, M
Farrer, MJ
机构
[1] Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA
[2] NIA, Neurogenet Lab, Bethesda, MD 20892 USA
[3] Brigham & Womens Hosp, Harvard Inst Med, Ctr Neurol Dis, Boston, MA 02115 USA
关键词
D O I
10.1093/hmg/ddg328
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Parkin gene (PRKN) encodes an E3 protein-ubiquitin ligase for which loss of function is associated with autosomal-recessive juvenile (<20 years) and early-onset Parkinsonism (<45 years). Although detailed pathological reports are scarce, brains from patients with homozygous exonic deletions demonstrate neuronal loss in the substantia nigra, albeit without the Lewy body pathology characteristic of idiopathic Parkinson's disease. However, there are rare descriptions of more florid pathology, including Lewy bodies and tau positive astrocytes in individuals with compound heterozygous mutations. In the present study we examined whether PRKN point mutations, leading to amino acid substitutions, may alter the cellular distribution of the protein produced. Wild-type Parkin was homogeneously distributed throughout the cytoplasm with a small amount of protein in the nucleus after transfection into human embryonic kidney cells. Mutant isoforms with A82E, G328E and C431F amino acid substitutions were also normally distributed. However, two mutant isoforms, R256C and R275W, within RING finger 1 of the Parkin protein (238-293 amino acids), produced an unusual distribution of the protein, with large cytoplasmic and nuclear inclusions. We have replicated this observation in primary cultured neurons and demonstrate, by the accumulation/co-localization of cytoskeletal protein vimentin, that the inclusion bodies are aggresomes, a cellular response to misfolded protein.
引用
收藏
页码:2957 / 2965
页数:9
相关论文
共 50 条
[1]  
ARDLEY HC, 2003, IN PRESS MOL BIOL CE
[2]   The parkin gene and its phenotype [J].
Bonifati, V ;
De Michele, G ;
Lücking, CB ;
Dürr, A ;
Fabrizio, E ;
Ambrosio, G ;
Vanacore, N ;
De Mari, M ;
Marconi, R ;
Capus, L ;
Breteler, MMB ;
Gasser, T ;
Oostra, B ;
Wood, N ;
Agid, Y ;
Filla, A ;
Meco, G ;
Brice, A .
NEUROLOGICAL SCIENCES, 2001, 22 (01) :51-52
[3]  
Burke RE, 1998, J NEUROCHEM, V71, P517
[4]   Parkin is metabolized by the ubiquitin/proteosome system [J].
Choi, P ;
Ostrerova-Golts, N ;
Sparkman, D ;
Cochran, E ;
Lee, JM ;
Wolozin, B .
NEUROREPORT, 2000, 11 (12) :2635-2638
[5]   Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1:: implications for Lewy-body formation in Parkinson disease [J].
Chung, KKK ;
Zhang, Y ;
Lim, KL ;
Tanaka, Y ;
Huang, H ;
Gao, J ;
Ross, CA ;
Dawson, VL ;
Dawson, TM .
NATURE MEDICINE, 2001, 7 (10) :1144-1150
[6]   Parkin's substrates and the pathways leading to neuronal damage [J].
Cookson, MR .
NEUROMOLECULAR MEDICINE, 2003, 3 (01) :1-13
[7]   Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture [J].
Cooper, JK ;
Schilling, G ;
Peters, MF ;
Herring, WJ ;
Sharp, AH ;
Kaminsky, Z ;
Masone, J ;
Khan, FA ;
Delanoy, M ;
Borchelt, DR ;
Dawson, VL ;
Dawson, TM ;
Ross, CA .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :783-790
[8]   Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 [J].
Cummings, CJ ;
Mancini, MA ;
Antalffy, B ;
DeFranco, DB ;
Orr, HT ;
Zoghbi, HY .
NATURE GENETICS, 1998, 19 (02) :148-154
[9]   Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain [J].
Fallon, L ;
Moreau, F ;
Croft, BG ;
Labib, N ;
Gu, WJ ;
Fon, EA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :486-491
[10]   Lewy bodies and parkinsonism in families with parkin mutations [J].
Farrer, M ;
Chan, P ;
Chen, R ;
Tan, L ;
Lincoln, S ;
Hernandez, D ;
Forno, L ;
Gwinn-Hardy, K ;
Petrucelli, L ;
Hussey, J ;
Singleton, A ;
Tanner, C ;
Hardy, J ;
Langston, JW .
ANNALS OF NEUROLOGY, 2001, 50 (03) :293-300